CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Açaí palm berry extract - natural productWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug646 Convalescent Immune Plasma Wiki 1.00
drug1822 Placebo Wiki 0.06

Correlated MeSH Terms (4)


Name (Synonyms) Correlation
D013577 Syndrome NIH 0.11
D055371 Acute Lung Injury NIH 0.10
D012127 Respiratory Distress Syndrome, Newborn NIH 0.10
D012128 Respiratory Distress Syndrome, Adult NIH 0.09

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Randomized Clinical Trial of Açaí Palm Berry Extract as an Intervention in Patients Diagnosed With COVID-19

The Açaí trial will be testing if the açaí berry extract, a safe natural product with anti-inflammatory properties, can be used as a treatment option in adult patients with COVID-19 in the community.

NCT04404218 COVID Dietary Supplement: Açaí palm berry extract - natural product Other: Placebo

Primary Outcomes

Description: Symptom comparison between patients from the treatment vs control group, using an ordinal symptom scale based on the WHO scale. Patients who were hospitalized will be classified according to their worst score over 30 days and non-hospitalized patients according to their score at 30 days.

Measure: 7-point ordinal symptom scale

Time: 30 days

Secondary Outcomes

Description: First occurrence of all-cause mortality or need for mechanical ventilation

Measure: The composite of all-cause mortality and need for mechanical ventilation

Time: 30 days

Description: First occurrence of all-cause mortality or hospitalization

Measure: The composite of all-cause mortality and hospitalization

Time: 30 days

Description: All-cause mortality

Measure: All-cause mortality

Time: 30 days

Description: Need for mechanical ventilation

Measure: Need for mechanical ventilation

Time: 30 days

Description: Need for hospitalization

Measure: Need for hospitalization

Time: 30 days


No related HPO nodes (Using clinical trials)